Verici Dx signs licensing deal with Thermo Fisher for kidney rejection test
Verici Dx plc, a pioneer in clinical diagnostics for organ transplant, has announced an exclusive global licensing agreement with Thermo Fisher Scientific, a world leader in science services, to develop a diagnostic assay for early kidney rejection risk assessment. Exclusive Licensing Terms The agreement provides Thermo Fisher with exclusive rights to develop and market the […]